Pharmaceutical and biotech companies are faced with a range of challenges across clinical development, clinical operations, competitive positioning and regulatory submission. As the single largest area of spend for drug development, implementing a cost-effective clinical strategy is imperative to expedite your clinical trials timelines, keep track of trial milestones and navigate the regulatory environment.
Unlock hidden insights to accelerate data-driven decisions across the research and development (R&D) lifecycle with the Cortellis suite of life science intelligence solutions. Enable precise, actionable insights into your unique trial needs – from early discovery and clinical development through regulatory submission and commercialization – leveraging the broadest and deepest sources of curated intelligence.
Bring speed and certainty across the development lifecycle.
Accelerate your research and maximize your chances of success.
"...Researchers can identify pathways that may be involved in processes under study, come up with hypotheses and ways of testing them."
Have greater confidence in your clinical and regulatory strategies.
"The global regulatory comparisons are very useful to compare specific issues between regions."
"The quality, accuracy and depth of information creates a total picture on which my customers can wholly rely."
Invest in the right products and the right markets at the right time.
"Newport has been a great investment for us, saving us time and money, while improving productivity."
Access exclusive deals intelligence that covers all types of partnerships and get a comprehensive foundation for analysis and decision-making with Cortellis Digital Health Intelligence.
Drugs and biologics
Regulatory reference documents
Our accredited global alliance program delivers value-added solutions by combining offerings from Clarivate with other technology and service providers. Partner with us to drive profitable growth, increase revenue and deliver greater value to your customers.
Contact us to learn more about how we support pharma and biotech companies.